Has Access to HCV Therapy Changed for Patients With Mental Health or Substance Use Disorders in the DAA Period?
Hepatology - United States
doi 10.1002/hep.30171
Full Text
Open PDFAbstract
Available in full text
Date
December 18, 2018
Authors
Publisher
Wiley